Study Evaluating the Efficacy of Different Mixes of HMO-2FL + Humiome® Post LB on IBS Gastrointestinal Symptoms

NARecruitingINTERVENTIONAL
Enrollment

402

Participants

Timeline

Start Date

March 27, 2025

Primary Completion Date

December 30, 2025

Study Completion Date

March 15, 2026

Conditions
IBS (Irritable Bowel Syndrome)
Interventions
DIETARY_SUPPLEMENT

MIX 1

Humiome® Post LB postbiotic 300 mg , Human Milk Oligosaccharides 2'-Ofucosyllactose 300 mg 1 capsule per day Orally

DIETARY_SUPPLEMENT

MIX 2

Humiome® Post LB postbiotic 100 mg Human Milk Oligosaccharides 2'-O-fucosyllactose 500 mg 1 capsule per day Orally

DIETARY_SUPPLEMENT

Placebo

Microcrystalline cellulose 1 capsule per day Orally

Trial Locations (12)

110058

RECRUITING

Dr. Naresh Bansal's Gastro & Liver Clinic, New Delhi

221005

RECRUITING

Samvedna Hospital, New Colony

302017

RECRUITING

Jaipur National University Institute of Medical Sciences and Research Centre, Jaipur

400706

RECRUITING

D Y Patil, Navi Mumbai

RECRUITING

D Y Patil Hospital, Medical college and research centre, Thāne

411002

RECRUITING

Dhanwantari Hospital, Pune

411041

RECRUITING

Silver Birch, Pune

412201

RECRUITING

Vishwaraj hospital, Pune

416012

RECRUITING

Aster Aadhar Hospital, Kolhāpur

421201

RECRUITING

Shivam Hospital, Dombivali

500004

RECRUITING

Gleneagles Global Hospitals, Hyderabad

586103

RECRUITING

Shri. B. M. PatilMedical College,Hospital andResearch Centre, Vijayapura

All Listed Sponsors
lead

DSM Nutritional Products, Inc.

INDUSTRY